Reticulocyte hemoglobin content.

Anemia of chronic disease Chronic kidney disease Iron deficiency Reticulocyte hemoglobin content Thalassemia trait

Journal

Clinica chimica acta; international journal of clinical chemistry
ISSN: 1873-3492
Titre abrégé: Clin Chim Acta
Pays: Netherlands
ID NLM: 1302422

Informations de publication

Date de publication:
May 2020
Historique:
received: 16 10 2019
revised: 30 01 2020
accepted: 30 01 2020
pubmed: 6 2 2020
medline: 22 6 2021
entrez: 5 2 2020
Statut: ppublish

Résumé

Iron deficiency leads to the suppression of hemoglobin (Hb) synthesis and induces metabolic disorders. In contrast, iron overload not only reduces the iron utilization efficiency but also induces oxidative stress. Iron metabolism in the body is closely regulated by hepcidin, a short peptide produced by the liver. Unfortunately, conventional iron indices may not always accurately reflect the iron status. For example, Hb concentration assessed using mature erythrocytes do not accurately reflect the real-time iron status due to their long lifespan. Reticulocytes are differentiated from erythroblasts after Hb synthesis and transform into mature erythrocytes in 1-2 days upon release into peripheral blood. Thus, Hb content in reticulocytes (Hb-ret) is more reflective of real-time Hb synthesis. Moreover, Hb-ret is affected only by the amount of iron intake as long as there is no hematopoietic disorder. Reticulocyte Hb content (CHr) can be accurately and inexpensively measured as Hb-ret by commercial H*3 or ADVIA hematology analyzers. CHr has been shown to be more effective than other indices of iron metabolism for the diagnosis of iron deficiency, for early detection of the therapeutic effects of iron therapy, and for differentiation of the beta thalassemia trait.

Identifiants

pubmed: 32014518
pii: S0009-8981(20)30052-8
doi: 10.1016/j.cca.2020.01.032
pii:
doi:

Substances chimiques

Hemoglobins 0
Iron E1UOL152H7

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

138-145

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Chie Ogawa (C)

Maeda Institute of Renal Research, 6F-1-403 Kosugi-cho, Nakahara-ku, Kawasaki, Kanagawa 211-0063, Japan; Biomarker Society, INC, 6F-1-403 Kosugi-cho, Nakahara-ku, Kawasaki, Kanagawa, Japan. Electronic address: tato.ogawa@gmail.com.

Ken Tsuchiya (K)

Department of Blood Purification, Tokyo Women's Medical University, 8-1 Kawadacho, Shinjuku-ku, Tokyo 162-8666, Japan; Biomarker Society, INC, 6F-1-403 Kosugi-cho, Nakahara-ku, Kawasaki, Kanagawa, Japan. Electronic address: tsuchiya@twmu.ac.jp.

Kunimi Maeda (K)

Maeda Institute of Renal Research, 6F-1-403 Kosugi-cho, Nakahara-ku, Kawasaki, Kanagawa 211-0063, Japan; Biomarker Society, INC, 6F-1-403 Kosugi-cho, Nakahara-ku, Kawasaki, Kanagawa, Japan. Electronic address: kuni@maeda-irr.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH